Press release 29th January 2018 Nicholas Cross appointed to guide development and growth of the Company Oxford, UK, 29th January 2018: Aigenpulse Ltd., (Aigenpulse), a company at the forefront of employing data technologies and advanced machine learning to significantly reduce the time and money needed to create new drugs, today announced the appointment of Mr […]